Why this broker sees 40% upside for the A2 Milk (ASX:A2M) share price

Here's why this broker likes A2 Milk…

| More on:
Broker looking at the share price on her laptop with green and red points in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The A2 Milk share price has been smashed over the last 12 months.
  • The team at Bell Potter believe this has created a buying opportunity for investors.
  • The broker sees 40% upside for its shares over the next 12 months.

The A2 Milk Company Ltd (ASX: A2M) share price has been a very poor performer over the last 12 months.

Since this time last year, the struggling infant formula company's shares have lost 40% of their value.

This means the A2 Milk share price is now down by over 70% since the middle of 2020.

Is the weakness in the A2 Milk share price a buying opportunity?

Opinion remains largely divided on the A2 Milk share price. However, one broker that is brave enough to recommend the embattled company as a buy is Bell Potter.

According to a recent note, the broker has a buy rating and $7.70 price target on the company's shares.

Based on the current A2 Milk share price of $5.38, this implies potential upside of 43% for investors over the next 12 months.

What did the broker say?

Bell Potter saw enough positives in A2 Milk's half year results last month to remain positive on the company.

It commented: "Our Buy rating remains unchanged. We saw plenty to like in this result: (1) growth in stage 1 market share in the MBS [mother and baby store] channel from 2.1% to 2.5% (indicative of new customer recruitment); (2) a beat in China direct channels sales in 1H22 and a closer alignment of sell-in and sell-out levels in 2Q22; (3) reinvestment of outperformance into marketing, to support FY23-24e revenue growth; and (4) progress on articulating a margin capture strategy at MVM."

Importantly, Bell Potter has not made any material changes to its earnings estimates following its results. It continues to expect the company's underlying net profit to be double FY 2021's levels in FY 2024.

Based on this, the broker estimates that the A2 Milk share price currently trades at approximately 28x FY 2024 earnings. While this is not conventionally cheap, Bell Potter appears to believe it deserves to trade at this level.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Electric vehicle being charged.
Broker Notes

Macquarie names its top ASX lithium stock picks

Macquarie has named its four top ASX-listed lithium stocks as prices for the critical battery metal rebound.

Read more »

A young man in a blue suit sits on his desk cross-legged with his phone in his hand looking slightly crazed.
Broker Notes

Don't sell! Experts pick 3 ASX All Ords shares worth holding despite major price shifts

Let's find out why.

Read more »

Excited elderly woman on a swing.
Broker Notes

After crashing 27% yesterday, should investors buy Regis Healthcare shares in the dip?

Even after yesterday's 27% decline, Regis Healthcare shares are up more than 560% in five years.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Bell Potter just put a buy rating on this ASX 200 stock

Let's see which high-flying stock has been tipped to keep rising.

Read more »

A happy man and woman sit having a coffee in a cafe while she holds up her phone to show him the ASX shares that did best today.
Broker Notes

JP Morgan initiates coverage on Sigma Healthcare shares with an overweight rating

Sigma Healthcare shares have soared more than 100% in the past year.

Read more »

Businessman holding bear figurine in one palm and bull figurine in other
Broker Notes

One ASX 300 stock to buy and one to sell: expert

Investors should be buying only one of these shares.

Read more »

Engineer on a laptop.
Broker Notes

One broker has upgraded Santos following the collapse of its takeover

RBC Capital Markets says Santos is well-positioned and looking cheap after a takeover for the company fell over.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »